{"transactions":[{"id":1152317,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-05-12T20:15:32.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":303100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on February 27, 2026, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":303100,"derivative":{"exercise_price":1.26,"expiration_date":"2035-05-08","underlying":"Class A Ordinary Shares","underlying_shares":303100},"source":{"system":"sec-edgar","filing":"0001415889-25-012656","document":"form4-05122025_040525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925012656/form4-05122025_040525.xml","form_type":"4"}},{"id":1267556,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-02-14T21:26:09.000Z","date":"2024-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":420519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":420519},"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267555,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":true,"shares":420519,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were distributed by JATT to the Reporting Person for no additional consideration."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2023-04-19","expiration_date":"2028-03-20","underlying":"Class A Ordinary Shares","underlying_shares":420519},"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267554,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":126155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported warrants were exchanged for Class A Ordinary Shares (\"Ordinary Shares\") pursuant to an exchange offer from the Issuer. Each warrant holder whose warrants were exchanged pursuant to the exchange offer received 0.30 Ordinary Shares for each warrant tendered by such holder and exchanged. No fractional Ordinary Shares were issued pursuant to the exchange offer, with fractional shares paid in cash (without interest). The foregoing description of the exchange offer does not purport to be complete and is subject to, and qualified in its entirety by, the S-4 of the Issuer filed on July 12, 2024, as amended, which is incorporated herein by reference."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267553,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-28","kind":"other","planned":false,"acquired":true,"shares":355880,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1267552,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Ordinary Shares","published_at":"2025-02-14T21:26:09.000Z","date":"2023-09-22","kind":"other","planned":false,"acquired":true,"shares":35484,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Class A ordinary shares were distributed by JATT Ventures L.P. (\"JATT\") to the Reporting Person for no additional consideration."}],"balance_after":517519,"source":{"system":"sec-edgar","filing":"0001415889-25-004111","document":"form5-02142025_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588925004111/form5-02142025_090206.xml","form_type":"5"}},{"id":1472206,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2024-06-21T22:10:14.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":420000,"derivative":{"exercise_price":3.38,"expiration_date":"2034-06-18","underlying":"Class A Ordinary Shares","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001415889-24-017862","document":"form4-06212024_060610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000141588924017862/form4-06212024_060610.xml","form_type":"4"}},{"id":1882809,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":19775,"kind":"person","name":"Badial Verender S.","position":1,"cik":"0001870327","reported_name":"Badial Verender S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-05-23T01:15:41.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Employee Share Option is a nil cost option granted under the Issuer's 2023 Equity Incentive Plan and the applicable UK Subplan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shall become exercisable on May 18, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter."}],"balance_after":575000,"derivative":{"exercise_price":0.01,"expiration_date":"2033-05-18","underlying":"Class A Ordinary Shares","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001104659-23-063311","document":"tm2316481-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000110465923063311/tm2316481-1_4seq1.xml","form_type":"4"}}]}